Related references
Note: Only part of the references are listed.Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications
Loubna El Harrad et al.
SENSORS (2018)
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2017)
A class of carbonic anhydrase I - selective activators
Erol Licsandru et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
Daniela Vullo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Brucella suis carbonic anhydrases and their inhibitors: Towards alternative antibiotics?
Stephan Kohler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Comparison of the Sulfonamide Inhibition Profiles of the - and -Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei
Daniela Vullo et al.
MOLECULES (2017)
Using Prokaryotes for Carbon Capture Storage
Natalie Hicks et al.
TRENDS IN BIOTECHNOLOGY (2017)
Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance
Clemente Capasso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T. Supuran et al.
METABOLITES (2017)
Sulfonamide inhibition profiles of the β-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Burkholderia pseudomallei γ-carbonic anhydrase is strongly activated by amino acids and amines
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines
Nagwa M. Abdel Gawad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Bortezomib inhibits bacterial and fungal β-carbonic anhydrases
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Carbonic anhydrase activators: Activation of the β-carbonic anhydrase from Malassezia globosa with amines and amino acids
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches
Giannamaria Annunziato et al.
CHEMMEDCHEM (2016)
An Overview of the Carbonic Anhydrases from Two Pathogens of the Oral Cavity: Streptococcus mutans and Porphyromonas gingivalis
Clemente Capasso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016)
Carrie Lomelino et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
CA IX stratification based on cancer treatment: a patent evaluation of US2016/0002350
Claudiu T. Supuran
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents
Jorge R. A. Diaz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Cloning, expression and purification of the complete domain of the η-carbonic anhydrase from Plasmodium fakiparum
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences
Claudiu T. Supuran et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Structure Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic Anhydrase
Joyanta K. Modak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations
Ylenia Cau et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets
Claudiu T. Supuran
PATHOGENS (2016)
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa
Melissa A. Pinard et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense
Giuseppina De Simone et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans
Nurcan Dedeoglu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors
C. Capasso et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Acetazolamide for the treatment of idiopathic intracranial hypertension
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Acetazolamide for the treatment of idiopathic intracranial hypertension
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Marta Ferraroni et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2015)
The η-class carbonic anhydrases as drug targets for antimalarial agents
Claudiu T. Supuran et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties
Ahmed M. Alafeefy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis
Ahmed M. Alafeefy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Building a Comprehensive Mill-Level Database for the Industrial Sectors Integrated Solutions (ISIS) Model of the US Pulp and Paper Sector
Nabanita Modak et al.
PLOS ONE (2015)
Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties
Ahmed M. Alafeefy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-The η-carbonic anhydrases
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors
Laura De Luca et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N′-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII
Beata Zolnowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules
Shalini Singh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis
Mariangela Ceruso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditions
Mayra Cobaxin et al.
MICROBIAL PATHOGENESIS (2014)
X-ray structure of the first 'extremo-α-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1
Anna Di Fiore et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
The extremo-α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The extremo-α-carbonic anhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA known, is highly activated by amino acids and amines
Atilla Akdemir et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1
Jean-Yves Winum et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review
Mayank Aggarwal et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Antiglaucoma carbonic anhydrase inhibitors: a patent review
Emanuela Masini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)
Simona Maria Monti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005-2013)
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
The first activation study of a bacterial carbonic anhydrase (CA). The thermostable α-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1
Viviana De Luca et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Novel therapies for glaucoma: a patent review 2007-2011
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Update on carbonic anhydrase inhibitors: a patent review (2008-2011)
Mayank Aggarwal et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Sulfonamides: a patent review (2008-2012)
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
DNA Cloning, Characterization, and Inhibition Studies of an α-Carbonic Anhydrase from the Pathogenic Bacterium Vibrio cholerae
Sonia Del Prete et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Immobilized carbonic anhydrase on hollow fiber membranes accelerates CO2 removal from blood
David T. Arazawa et al.
JOURNAL OF MEMBRANE SCIENCE (2012)
A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth
Pascale Joseph et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Carbonic anhydrase inhibitors and activators for novel therapeutic applications
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2011)
The beta-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007-2009
Sally-Ann Poulsen
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Bicarbonate Induces Vibrio cholerae Virulence Gene Expression by Enhancing ToxT Activity
Basel H. Abuaita et al.
INFECTION AND IMMUNITY (2009)
The alpha and beta classes carbonic Anhydrases from Helicobacter pylori as novel drug targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Carbonic anhydrases - An overview
Claudiu T. Supuran
CURRENT PHARMACEUTICAL DESIGN (2008)
Cloning, polymorphism, and inhibition of β-carbonic anhydrase of Helicobacter pylori
Saori Morishita et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Carbonic anhydrase inhibitors:: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori
I Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo:: A pilot study
R Shahidzadeh et al.
HELICOBACTER (2005)
Why is carbonic anhydrase essential to Escherichia coli?
C Merlin et al.
JOURNAL OF BACTERIOLOGY (2003)
Carbonic anhydrase is essential for growth of Ralstonia eutropha at ambient CO2 concentrations
B Kusian et al.
JOURNAL OF BACTERIOLOGY (2002)
Share Paper
